# EDBI Pte Ltd

> Institutional holdings reported to the SEC as of Q4 2024 on Form 13F. CIK 1913506. Source: https://holderbook.com/funds/1913506-edbi-pte-ltd/

- Reported value: $94.4M
- Positions: 14
- Weight of the ten largest: 98.5%
- Filed: 2025-02-04

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| JOBY AVIATION INC | [JOBY](https://holderbook.com/stocks/JOBY/) | $24.6M | 3,022,543 | 26.0% | 13 |
| SNOWFLAKE INC | [SNOW](https://holderbook.com/stocks/SNOW/) | $22.4M | 145,009 | 23.7% | 13 |
| GRAB HOLDINGS LIMITED | [GRAB](https://holderbook.com/stocks/GRAB/) | $13.3M | 2,822,035 | 14.1% | 13 |
| AVEPOINT INC | [AVPT](https://holderbook.com/stocks/AVPT/) | $11.6M | 700,000 | 12.2% | 13 |
| SPRINKLR INC | [CXM](https://holderbook.com/stocks/CXM/) | $9.4M | 1,110,777 | 9.9% | 13 |
| PLANET LABS PBC | [PL](https://holderbook.com/stocks/PL/) | $4.3M | 1,065,593 | 4.6% | 13 |
| NUVATION BIO INC | [NUVB](https://holderbook.com/stocks/NUVB/) | $3.4M | 1,270,504 | 3.6% | 13 |
| ERASCA INC | [ERAS](https://holderbook.com/stocks/ERAS/) | $2.2M | 888,888 | 2.4% | 13 |
| MARQETA INC | [MQ](https://holderbook.com/stocks/MQ/) | $969.3K | 255,753 | 1.0% | 12 |
| GITLAB INC | [GTLB](https://holderbook.com/stocks/GTLB/) | $910.1K | 16,150 | 1.0% | 8 |
| OSCAR HEALTH INC | [OSCR](https://holderbook.com/stocks/OSCR/) | $816.3K | 60,740 | 0.9% | 3 |
| HASHICORP INC | [HCP](https://holderbook.com/stocks/HCP/) | $222.4K | 6,500 | 0.2% | 3 |
| NOVABRIDGE BIOSCIENCES | [NBP](https://holderbook.com/stocks/NBP/) | $188.8K | 222,136 | 0.2% | 13 |
| KEROS THERAPEUTICS INC | [KROS](https://holderbook.com/stocks/KROS/) | $160.0K | 10,105 | 0.2% | 13 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q4 2024 | +31.7% | +2.1% | +29.5% | 100% |
| Q3 2024 | -4.3% | +5.4% | -9.8% | 100% |
| Q2 2024 | -2.2% | +4.0% | -6.2% | 100% |
| Q1 2024 | -9.4% | +10.0% | -19.4% | 100% |
| Q4 2023 | +8.4% | +11.2% | -2.8% | 100% |
| Q3 2023 | -16.9% | -3.6% | -13.4% | 100% |
| Q2 2023 | +37.3% | +8.3% | +29.0% | 100% |
| Q1 2023 | +9.3% | +7.0% | +2.2% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2024 | $94.4M | 14 |
| Q3 2024 | $74.0M | 16 |
| Q2 2024 | $88.4M | 17 |
| Q1 2024 | $88.9M | 15 |
| Q4 2023 | $101.1M | 17 |
| Q3 2023 | $92.3M | 18 |
| Q2 2023 | $123.8M | 18 |
| Q1 2023 | $89.3M | 20 |
| Q4 2022 | $78.5M | 19 |
| Q3 2022 | $95.0M | 26 |
| Q2 2022 | $107.9M | 25 |
| Q1 2022 | $150.1M | 22 |